These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial. Sakata Y; Shiba N; Takahashi J; Miyata S; Nochioka K; Miura M; Takada T; Saga C; Shinozaki T; Sugi M; Nakagawa M; Sekiguchi N; Komaru T; Kato A; Fukuchi M; Nozaki E; Hiramoto T; Inoue K; Goto T; Ohe M; Tamaki K; Ibayashi S; Ishide N; Maruyama Y; Tsuji I; Shimokawa H; ; Eur Heart J; 2015 Apr; 36(15):915-23. PubMed ID: 25637937 [TBL] [Abstract][Full Text] [Related]
6. Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study. Kimmoun A; Cotter G; Davison B; Takagi K; Addad F; Celutkiene J; Chioncel O; Solal AC; Diaz R; Damasceno A; Duengen HD; Filippatos G; Goncalvesova E; Merai I; Metra M; Ponikowski P; Privalov D; Sliwa K; Sani MU; Voors AA; Shogenov Z; Mebazaa A Eur J Heart Fail; 2019 Nov; 21(11):1459-1467. PubMed ID: 31423712 [TBL] [Abstract][Full Text] [Related]
7. Long-Term Adherence to Renin-Angiotensin System Inhibitors and β-Blockers After Heart Failure Hospitalization in Senior Patients. Qin X; Hung J; Teng TK; Briffa T; Sanfilippo FM J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):531-540. PubMed ID: 32500739 [TBL] [Abstract][Full Text] [Related]
8. Directly Measured Adherence to Treatment in Chronic Heart Failure: LEVEL-CHF Registry. Jelínek L; Václavík J; Ramík Z; Pavlů L; Benešová K; Jarkovský J; Lazárová M; Janečková H; Spurná J; Táborský M Am J Med Sci; 2021 Apr; 361(4):491-498. PubMed ID: 33781390 [TBL] [Abstract][Full Text] [Related]
9. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey. Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L; Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461 [TBL] [Abstract][Full Text] [Related]
10. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial. Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY JAMA Cardiol; 2020 Jan; 5(1):38-46. PubMed ID: 31721978 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Medication Management and Medication Adherence for Chronic Conditions. Brummel A; Carlson AM J Manag Care Spec Pharm; 2016 Jan; 22(1):56-62. PubMed ID: 27015052 [TBL] [Abstract][Full Text] [Related]
12. Imaging-Guided Cardioprotective Treatment in a Community Elderly Population of Stage B Heart Failure. Yang H; Negishi K; Wang Y; Nolan M; Marwick TH JACC Cardiovasc Imaging; 2017 Mar; 10(3):217-226. PubMed ID: 28279368 [TBL] [Abstract][Full Text] [Related]
13. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study. Tsuyuki RT; Yusuf S; Rouleau JL; Maggioni AP; McKelvie RS; Wiecek EM; Wang Y; Pogue J; Teo KK; White M; Avezum A; Latini R; Held P; Lindgren E; Probstfield J Can J Cardiol; 1997 Dec; 13(12):1166-74. PubMed ID: 9444298 [TBL] [Abstract][Full Text] [Related]
14. Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study). Gupta P; Voors AA; Patel P; Lane D; Anker SD; Cleland JGF; Dickstein K; Filippatos G; Lang CC; van Veldhuisen DJ; Metra M; Zannad F; Samani NJ; Jones DJL; Squire IB; Ng LL Eur J Heart Fail; 2021 Jul; 23(7):1182-1190. PubMed ID: 33759308 [TBL] [Abstract][Full Text] [Related]
16. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW; Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013 [TBL] [Abstract][Full Text] [Related]
17. The effects of medication supply on hospitalizations and health-care costs in patients with chronic heart failure. Dilokthornsakul P; Chaiyakunapruk N; Nimpitakpong P; Jeanpeerapong N; Sruamsiri R Value Health; 2012; 15(1 Suppl):S9-14. PubMed ID: 22265074 [TBL] [Abstract][Full Text] [Related]
18. Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials. Hansen MR; Hróbjartsson A; Videbæk L; Ennis ZN; Pareek M; Paulsen NH; Broe M; Olesen M; Pottegård A; Damkier P; Hallas J Am J Med; 2020 Jun; 133(6):e280-e289. PubMed ID: 32173347 [TBL] [Abstract][Full Text] [Related]
19. The impact of pharmacist/physician care on quality of life in elderly heart failure patients: results of the PHARM-CHF randomized controlled trial. Schulz M; Griese-Mammen N; Schumacher PM; Anker SD; Koehler F; Ruckes C; Rettig-Ewen V; Wachter R; Trenk D; Böhm M; Laufs U ESC Heart Fail; 2020 Dec; 7(6):3310-3319. PubMed ID: 32700409 [TBL] [Abstract][Full Text] [Related]